2D3] has been reported to stimulate lung maturity, alveolar type II cell differentiation, and pulmonary surfactant synthesis in rat lung. We hypothesized that 1,25(OH) 2D3 stimulates expression of surfactant protein-A (SP-A), SP-B, and SP-C in human fetal lung and type II cells. We found that immunoreactive vitamin D receptor was detectable in fetal lung tissue and type II cells only when incubated with 1,25(OH)2D3. 1,25(OH)2D3 significantly decreased SP-A mRNA in human fetal lung tissue but did not significantly decrease SP-A protein in the tissue. In type II cells, 1,25(OH)2D3 alone had no significant effect on SP-A mRNA or protein levels but reduced SP-A mRNA and protein in a dose-dependent manner when the cells were incubated with cAMP. SP-A mRNA levels in NCI-H441 cells, a nonciliated bronchiolar epithelial (Clara) cell line, were decreased in a dose-dependent manner in the absence or presence of cAMP. 1,25(OH)2D3 had no significant effect on SP-B mRNA levels in lung tissue but increased SP-B mRNA and protein levels in type II cells incubated in the absence or presence of cAMP. Expression of SP-C mRNA was unaffected by 1,25(OH)2D3 in lung tissue incubated Ϯ cAMP. These results suggest that regulation of surfactant protein gene expression in human lung and type II cells by 1,25(OH)2D3 is not coordinated; 1,25(OH)2D3 decreases SP-A mRNA and protein levels in both fetal lung tissue and type II cells, increases SP-B mRNA and protein levels only in type II cells, and has no effect on SP-C mRNA levels. alveolar type II cell; steroid hormone PULMONARY SURFACTANT IS a unique complex of phospholipids and proteins that maintains alveolar integrity by reducing surface tension at the alveolar air-liquid interface (15) and participates in host defense and the control of inflammation in the lung (16). Surfactant is composed of 90% lipids and 10% proteins by weight. Phosphatidylcholine, mostly dipalmitoyl phosphatidylcholine, constitutes 70 -80% of the lipid portion of surfactant. Several distinct lung-specific proteins make up the protein component of surfactant, surfactant protein-A (SP-A), SP-B, SP-C, and SP-D (23). Whereas the lipid portion of surfactant is largely responsible for its surface activity, the highly hydrophobic proteins SP-B and SP-C also play a direct role in influencing the surface tension-reducing properties of surfactant (54). On the other hand, SP-A and SP-D are hydrophilic members of the collectin family of proteins (25) that play important roles in the control of host defense and inflammation in the lung (16). Pulmonary alveolar type II epithelial cells that are positioned in the corners of the alveoli carry out the highly specialized functions of synthesizing, secreting, and reutilizing surfactant (36, 49). Surfactant synthesis is initiated in alveolar type II cells only after 75% of gestation is complete (43). Infants born before this period of gestation lack sufficient surfactant and are predisposed to develop respiratory distress syndrome, one of the leading causes of neonatal morbidity and mortality (4).
PULMONARY SURFACTANT IS a unique complex of phospholipids and proteins that maintains alveolar integrity by reducing surface tension at the alveolar air-liquid interface (15) and participates in host defense and the control of inflammation in the lung (16) . Surfactant is composed of 90% lipids and 10% proteins by weight. Phosphatidylcholine, mostly dipalmitoyl phosphatidylcholine, constitutes 70 -80% of the lipid portion of surfactant. Several distinct lung-specific proteins make up the protein component of surfactant, surfactant protein-A (SP-A), SP-B, SP-C, and SP-D (23) . Whereas the lipid portion of surfactant is largely responsible for its surface activity, the highly hydrophobic proteins SP-B and SP-C also play a direct role in influencing the surface tension-reducing properties of surfactant (54) . On the other hand, SP-A and SP-D are hydrophilic members of the collectin family of proteins (25) that play important roles in the control of host defense and inflammation in the lung (16) . Pulmonary alveolar type II epithelial cells that are positioned in the corners of the alveoli carry out the highly specialized functions of synthesizing, secreting, and reutilizing surfactant (36, 49) . Surfactant synthesis is initiated in alveolar type II cells only after 75% of gestation is complete (43) . Infants born before this period of gestation lack sufficient surfactant and are predisposed to develop respiratory distress syndrome, one of the leading causes of neonatal morbidity and mortality (4) .
The synthesis of surfactant by the fetal lung is regulated by a number of hormones, growth factors, and cytokines, some of which increase adenosine 3Ј,5Ј-cyclic monophosphate (cAMP) (36, 43) . Steroid hormones, in particular, have varied effects on the regulation of expression of surfactant lipids and proteins in fetal lung both in vivo and in vitro. Glucocorticoids have been shown to accelerate fetal lung development and surfactant synthesis (31) . In human fetal lung in organ culture, surfactant lipid synthesis and SP-B, SP-C (5, 8) , and SP-D (17) mRNA expression are increased in the presence of glucocorticoids, whereas regulation of SP-A mRNA is more complex. Glucocorticoids increase transcription of SP-A mRNA and expression of SP-A protein at low concentrations, but SP-A mRNA and protein levels are decreased at high concentrations of glucocorticoids due to destabilization of SP-A mRNA (11, 26, 41) . Retinoic acid increases expression of SP-B mRNA but decreases SP-A and SP-C mRNA in human fetal lung tissue in organ culture and in alveolar type II cells in culture (20, 21 ). These observations demonstrate that the regulation of fetal lung maturity and surfactant lipid and protein expression by hormones, and presumably their cognate receptors, is complex.
Another steroid hormone, the active form of 1␣,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ], has been shown to affect fetal lung development (39) . In fetal rat lung, 1,25(OH) 2 D 3 increases the synthesis and secretion of surfactant lipids (34, 35) and accelerates the appearance of the morphological features of alveolar type II cells (34) . Rat alveolar type II cells have been shown to contain the nuclear hormone receptor for 1,25(OH) 2 D 3 , which is responsible for many of its physiological effects (38) . Recently, a report has suggested that a natural metabolite of 1,25(OH) 2 D 3 increases surfactant phospholipid and SP-B mRNA and protein synthesis in human NCI-H441 cells (48) . Nevertheless, the effects of 1,25(OH) 2 D 3 on the expression of the various surfactant proteins in human fetal lung and epithelial cells have not been investigated. Therefore, we chose to determine the effects of 1,25(OH) 2 D 3 on steadystate levels of SP-A, SP-B, and SP-C mRNA in human fetal lung in organ culture, in isolated alveolar type II cells in primary culture, and in NCI-H441 cells. We hypothesized that 1,25(OH) 2 D 3 would stimulate expression of surfactant protein mRNA in human fetal lung and epithelial cells.
MATERIALS AND METHODS
Organ culture and alveolar type II isolation and primary culture. Lung tissue from midtrimester human abortuses was obtained from Advanced Bioscience Resources (Alameda, CA) in accordance with protocols approved by The Committee for the Protection of Human Subjects of the University of Texas-Houston Health Science Center. The tissues were minced (1-2 mm 3 ) and cultured on lens paper supported by stainless steel grids in serum-free RPMI-1640 medium (11875; GIBCO-BRL, Gaithersburg, MD) in the presence of dibutyryl cAMP (Bt 2cAMP, 1 mM, 104396; Boehringer Mannheim, Indianapolis, IN) as described previously (42) . After 5 days of organ culture with daily medium changes, alveolar type II cells were isolated from the lung explants in organ culture (3). As described previously, the lung explants were dissociated by digestion with collagenase type I (0.5 mg/ml, C-0130; Sigma Chemical, St. Louis, MO) and collagenase type IA (0.5 mg/ml, C-9891, Sigma Chemical) for 15 min at 37°C with vigorous pipetting. After collagenase digestion, the cells were treated with diethylaminoethyl-dextran hydrochloride (250 g/ml, D9885, Sigma Chemical), to eliminate fibroblasts, and incubated for 45 min with shaking at 37°C. The cells were pelleted at 400 g and plated (2-5 ϫ 10 6 cells per dish) onto 60-mm tissue culture dishes that were coated with extracellular matrix (ECM) derived from MadinDarby canine kidney (MDCK) cells (ATCC CRL 6253). The ECMcoated dishes were prepared from confluent monolayers of MDCK cells that were treated with deoxycholate (1%) for 5 min. The ECM dishes were washed three times with Hanks' balanced salt solution and stored at 37°C until use. Plated epithelial cell-enriched cultures were incubated overnight in RPMI-1640 with 10% fetal bovine serum. Dishes were washed twice with medium to eliminate dead and nonadherent cells and then incubated in RPMI-1640 without fetal bovine serum and in the absence or presence of the various required effectors. All human cell and tissue culture incubations were preformed in a humidified incubator at 37°C with 5% CO 2.
Cell culture of NCI-H441 cells. The lung adenocarcinoma cell line NCI-H441 (19, 44) was cultured in RPMI-1640 containing fetal bovine serum (10% vol/vol). When the cells were to be used for experiments, they were incubated in RPMI-1640 containing charcoalstripped dextran-treated fetal bovine serum (SH30068; Hyclone, Logan, UT) 24 h before treatment to eliminate possible effects from steroids in fetal bovine serum. All cell culture incubations were performed in a humidified incubator at 37°C with 5% CO 2.
Immunoblot analysis. Proteins were isolated as described previously (2) . In brief, cells were scraped from the plates and homogenized in ice-cold homogenization buffer [0.25 M sucrose, 10 mM Tris ⅐ HCl (pH 7.4), 1 mM EDTA, and 0.1 mM phenylmethylsulfonyl fluoride (PMSF)]. The homogenized samples were centrifuged at 600 g for 5 min to sediment nuclei and debris, and the resulting supernatant was assayed for protein content. Cellular proteins were subjected to one-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to nitrocellulose by electrophoretic transfer. The proteins on the resulting blots were analyzed for the presence of vitamin D receptor (VDR) using specific antibodies (RP-710; Affinity Bioreagents, Golden, CO). The resulting immune complexes were visualized using the chemiluminescence ECL system (Amersham Pharmacia Biotech, Piscataway, NJ). For SP-A immunoblot analysis, a rabbit anti-human SP-A antibody (1:1,000 dilution) (1) was used followed by peroxidase-conjugated goat anti-rabbit IgG (1: 160,000 dilution, A0545; Sigma Chemical). For SP-B immunoblot analysis, a commercially available rabbit anti-sheep SP-B antibody (AB3780; Chemicon International, Temecula, CA) was used followed by peroxidase-conjugated goat anti-rabbit IgG (1:16,000 dilution).
The immunoreactive proteins were detected with the chemiluminescence ECL system and recorded on high-performance chemiluminescence film for visualization of the resulting protein-antibody complexes.
Northern analysis of surfactant mRNA. Total RNA was extracted from the tissue and cells by homogenization in guanidinium isothiocyanate (4.0 M) using a tissue homogenizer. Cell extracts were centrifuged through a cesium chloride gradient (5.7 M), and the pelleted RNA was resuspended in water (13) . Total RNA (15 g) was electrophoresed, transferred to nitrocellulose, and probed using a 32 P-labeled rabbit SP-A cDNA, rabbit SP-B cDNA, or rabbit SP-C cDNA as described in detail previously (9, 10, 33) . Analysis of 18S rRNA was performed using an 80-bp 32 P-labeled 18S fragment (7339; Ambion, Austin, TX). The specific surfactant protein mRNA species were visualized by autoradiography using Kodak X-OMAT radiographic film.
Quantification of surfactant protein mRNA levels and SP-A protein levels. Quantification of the surfactant protein mRNA bands and 18S RNA bands visualized by Northern analysis and SP-A protein and ␤-actin protein visualized by immunoblot analysis was performed using the imaging and quantitation abilities of the ChemiGenius 2 imaging system (Syngene, Frederick, MD). The ChemiGenius 2 is an analysis system that features a Peltier-cooled charge-coupled device camera and Total Recall feature, which recreates every aspect of the capture of a particular image and ensures precise reproducibility of capture conditions from sample to sample. The system is linked to a computer for control and analysis via a fully integrated imageacquisition, archiving, and analysis package running in a Windows environment (InGenius BioImaging software: Genetools version 3.04 and GeneSnap version 6.03). An automatic and full analysis of the saved image can be performed with a report of the analysis generated.
Statistical analysis. All results are expressed as average Ϯ SE of three independent values. A nonparametric ANOVA method of analysis, Kruskal-Wallis, was used to determine the level of difference. P Ͻ 0.05 was considered to be significant. The analysis was performed using a software package by Number Cruncher Statistical Systems (Kaysville, UT). Figure  1 shows the results of the analysis. Levels of VDR were barely detectable in human fetal lung and human type II cells cultured in the absence of 1,25(OH) 2 D 3 (only visible when the blot was overexposed). However, when VDR was cultured in the presence of 1,25(OH) 2 D 3 , its levels increased dramatically in both human fetal lung tissues in organ culture and human alveolar type II cells in primary culture. These results suggest that 1,25(OH) 2 D 3 increased the amount of VDR in human fetal lung and in human alveolar type II cells. Normally, vitamin D induces stabilization of the VDR; unoccupied VDR is cytoplasmic and proteasome sensitive, whereas binding of the ligand results in a rapid accumulation of VDR in the nucleus. On the other hand, Caco-2 cells possess proteasome-resistant VDR in the absence or presence of ligand (27, 45) , making the lysate useful as a positive control for the presence of VDR. (10 Ϫ10 or 10 Ϫ7 M) Ϯ Bt 2 cAMP, and steady-state SP-A mRNA levels were determined. It is important to note that cAMP is added to the tissue and cells to both augment surfactant protein gene expression (36, 43) and to induce and maintain the differentiation of alveolar type II cells (3, 52) . Figure 2A shows a representative Northern analysis of SP-A mRNA present in these tissues. Quantification of the SP-A mRNA signal in human fetal lung determined by scanning densitometry of three Northern analyses is shown in Fig. 2B . As expected, the basal SP-A mRNA levels were very low in human fetal lung tissue at 18 -22 wk of gestation (day 0). SP-A mRNA levels increased slightly (twofold) by day 2 and increased significantly (18-fold) by day 4 of culture in vitro, indicating the expected differentiation of the tissue in organ culture (52) . Moreover, in tissue cultured in the presence of Bt 2 cAMP, the levels of SP-A mRNA were increased approximately two-to fourfold compared with tissue incubated in the absence of Bt 2 cAMP. 1,25(OH) 2 , and 10 Ϫ7 M) Ϯ Bt 2 cAMP. After 4 days in primary culture, the cells were harvested, and the RNA was isolated and subjected to Northern blot analysis. Figure 2A shows a representative Northern analysis of SP-A mRNA present in these cells. Quantification of the SP-A mRNA signal determined by scanning densitometry of three Northern analyses is shown in Fig. 2C Ϫ8 , and 10 Ϫ7 M) Ϯ Bt 2 cAMP. After 3 days in culture, the cells were harvested, and the RNA was isolated and subjected to Northern blot analysis. Figure 2D shows a quantification of the SP-A mRNA signal determined by scanning densitometry of three Northern analyses. As seen with the results using human alveolar type II cells in primary culture, Bt 2 cAMP caused an increase in the SP-A mRNA levels in NCI-H441 cells. In the absence of Bt 2 cAMP, lower concentrations of 1,25(OH) 2 M) Ϯ Bt 2 cAMP. After 4 days in primary culture, the cells were harvested, and the RNA was isolated and subjected to Northern blot analysis. Figure 4B is a quantification of the SP-B mRNA signal determined by scanning densitometry of three Northern analyses (a representative Northern analysis is shown at the top). SP-B mRNA levels were increased when the cells were incubated in the presence of Bt 2 cAMP. In cells incubated in the absence of Bt 2 cAMP, only the highest concentration of 1,25(OH) 2 D 3 had an effect on SP-B mRNA levels; the presence of the hormone at 10 Ϫ7 M increased the levels significantly. When type II cells were incubated in the presence of Bt 2 cAMP, a dose-dependent effect to increase SP-B mRNA levels was observed.
RESULTS

VDR is detectable in human fetal
1,25(OH) 2 D 3 generally reduces expression of SP-A in hu-
To Figure 5 is a quantification of the SP-C mRNA signal determined by scanning densitometry of three Northern analyses (a representative analysis is shown at the top). Unlike that seen with SP-A and SP-B mRNA levels, SP-C mRNA levels in human fetal lung are relatively high at day 0. These levels decrease (10-fold) by day 2 of culture and show no change at day 4. This result is not completely unexpected, since detectable levels of SP-C mRNA in lung tissue appear to decrease during later development (3). The presence of 1,25(OH) 2 D 3 had little effect on SP-C mRNA levels compared with tissue incubated in its absence. Again, as with SP-A and SP-B mRNA levels, the presence of Bt 2 cAMP increased the levels of SP-C mRNA. However, the presence of 1,25(OH) 2 D 3 did not significantly change the levels of SP-C mRNA in these tissues. These results indicate that 1,25(OH) 2 D 3 had little effect on SP-C mRNA levels in human fetal lung. We chose not to investigate the effects of 1,25(OH) 2 D 3 on SP-C mRNA levels in human type II pneumonocytes in primary culture because we have found previously that detectable levels of SP-C mRNA had to be induced by the addition of dexamethasone (3). We felt that the presence of another steroid hormone in the culture medium would only complicate the phenomenon investigated. 
DISCUSSION
The effects of steroid hormones, such as glucocorticoids (5, 8, 17, 31, 41) , retinoids (20, 21) , thyroid hormone (6, 47) , estrogen (14) , and testosterone (40, 53) , on the synthesis of various surfactant components, have been studied at length over the last two decades. 1,25(OH) 2 D 3 has been reported to accelerate fetal lung maturity and alveolar type II differentiation and to increase expression and secretion of surfactant lipids in rat lung tissue and rat type II cells (34, 35, 39 (38) .
To investigate the effect of 1,25(OH) 2 D 3 on surfactant protein gene expression in human fetal lung tissue, we used a previously described organ culture system in which undifferentiated lung tissue is allowed to spontaneously differentiate in vitro and Bt 2 cAMP is added to accelerate differentiation and increase numbers of type II cells in the tissue (52) . In human fetal lung, the major effect of 1,25(OH) 2 D 3 on surfactant protein gene expression was to decrease expression of SP-A mRNA, whereas no significant effect of 1,25(OH) 2 D 3 on SP-B and SP-C mRNA levels was observed. The inhibitory effect of 1,25(OH) 2 D 3 on SP-A mRNA was most apparent when the tissue was incubated in the presence of Bt 2 cAMP, although the inhibitory effect of 1,25(OH) 2 D 3 on SP-A mRNA levels also occurred in tissue incubated in the absence of Bt 2 cAMP. However, no significant effect of 1,25(OH) 2 D 3 on SP-A protein levels was observed in the tissue. Thus it seems that the only significant effect of 1,25(OH) 2 D 3 on surfactant protein gene expression in human fetal lung tissue is to reduce SP-A mRNA levels. This pattern of regulation of 1,25(OH) 2 D 3 on SP-A mRNA levels is the same as that found in human fetal lung tissue in organ culture incubated with increasing concentrations of the synthetic glucocorticoid steroid hormone dexamethasone (11) .
We then investigated the effect of 1,25(OH) 2 D 3 on surfactant protein gene expression in isolated human alveolar type II cells in primary culture. In this system, alveolar type II cells are isolated from differentiated human fetal lung tissue in organ and probed for the presence of SP-C mRNA using radiolabeled human SP-C cDNA. Shown is the resulting autoradiograph (top). Quantification of SP-C mRNA levels in human fetal tissue is shown at the bottom. The SP-C mRNA signal in autoradiographs was subjected to scanning densitometry, and the signal was normalized to the 18S RNA signal in each lane (not shown). Shown are the average levels Ϯ SE of normalized SP-C mRNA signal relative to levels at day 0 of culture from 3 determinations. culture and placed in primary culture (3). Bt 2 cAMP is added to maintain the type II cells in a differentiated state and to allow adequate expression levels of the surfactant genes for subsequent analysis. In these analyses, the effect of 1,25(OH) 2 D 3 on SP-C gene expression was not investigated since adequate levels of SP-C gene expression can be attained only in the presence of glucocorticoids, whose presence would confound the interpretation of the results.
We found that the presence of 1,25(OH) 2 D 3 reduced the levels of SP-A mRNA and protein in type II cells only when incubated in the presence of Bt 2 cAMP. There was no significant effect of the hormone on SP-A mRNA and protein levels in cells incubated without Bt 2 cAMP, but the levels of expression of SP-A in these cells were very low, and further reduction in the expression levels may not have been readily detected. (48) . NCI-H441 are derived from Clara cells of the lung rather than alveolar type II cells; they express SP-A and SP-B, but not SP-C, and do not contain the distinguishing feature of type II cells, lamellar bodies (19) . Despite the probable difference in origin between NCI-H441 cells and type II cells, the effect of 1,25(OH) 2 D 3 on SP-B expression in the two cell types is similar, but both differ from the results with the fetal lung in which 1,25(OH) 2 D 3 has no significant effect on SP-B mRNA expression.
The apparent incongruence between the effect of 1,25 (OH) 2 D 3 on expression of SP-B in fetal lung tissue in this study and in type II cells was quite unexpected in light of the fact that the regulation of SP-B expression by glucocorticoids in both tissue and cells is very similar (3, 11) . However, it should be recognized that the regulation of the expression of specific surfactant protein genes may be different in isolated lung epithelial cells compared with human fetal lung tissue. It has been proposed that the effects of glucocorticoids on alveolar type II physiology are mediated through the action of the fibroblast pneumonocyte factor (51), in which a secreted factor expressed by mesenchyme cells of the lung affects the synthesis of pulmonary surfactant components in alveolar type II epithelial cells. It is possible that some of the effects of 1,25(OH) 2 D 3 on surfactant protein gene expression in the lung may be altered when cells are isolated and incubated in culture in a relatively purified state in which there is no interaction or communication with other cell types of the lung. 1,25(OH) 2 D 3 may act directly on type II cells in primary culture to induce production of SP-B mRNA, whereas the compound may interact with many cell types of the lung that may produce factors Fig. 6 . Identification of putative VDR binding sites in the sequences flanking the promoters of the human SP-A1, SP-A2, SP-B, and SP-C genes. The sequences of the human surfactant proteins genes available in the GenBank database were scanned for the presence of perfect half-sites of the consensus sequence for the binding site of the VDR. The searches were restricted to promoter region extending from 1,500 bp of 5Ј-flanking sequences through the first exon and intron of each gene. The positions of the half-sites are indicated by underlines, and nucleotides that correspond to those present in the perfect consensus sequences are bolded. Only sequences that matched 9 or 12 nucleotides of the perfect sequences were considered. At the right are listed the putative binding receptor partners based on the sequences; VDR/VDR represents VDR homodimers, whereas RXR/VDR represents retinoic acid X receptor and VDR heterodimers. that act on type II and Clara cells of the lung to elicit no net change in SP-B mRNA expression.
On the other hand, it has been shown that the effects of retinoic acid, the ligand of the heterodimer partner for VDR, depend on the stage of development of the lung. Retinoic acid signaling is ubiquitous in developing lung, but during branching morphogenesis, retinoic acid signaling is suppressed in the epithelium by various mechanisms (32) . It has been shown that retinoic acid causes a dose-dependent inhibition of SP-A mRNA levels in human fetal lung in organ culture, and SP-B mRNA levels are increased in a dose-dependent manner, whereas SP-C gene expression is inhibited only at the highest levels of the agent (37) . However, retinoids causes dosedependent inhibition of SP-A, SP-B, and SP-C mRNA levels in cultured lung buds from 13.5-day gestational age rat embryos (12) . Perhaps the potential retinoic acid receptor partner to the VDR complicates regulation of the surfactant proteins by 1,25(OH) 2 D 3 . The effects of retinoic acid on surfactant protein gene expression in our type II cell primary culture system conditions have not been defined and may be different from that reported in developing lung or that we see in our organ culture system. Steroid hormones have been described as exerting their influence on cellular processes by activation of the hormone's cognate receptor by binding to the receptor and altering transcription of a specific promoter by binding to DNA proximal to the promoter region (7, 18) , although it is apparent that steroid hormones may have nongenomic effects on cellular physiology as well (50) . The VDR influences transcription of a number of genes by the binding of VDR homodimers or vitamin D/retinoid X receptor (RXR) heterodimers to their cognate recognition sequences or vitamin D responsive elements (VDREs) that consist of an imperfect direct repeat of a core hexanucleotide sequence, (G/A)GGT(G/C)A, with a spacer region of three or six nucleotides separating each half-element (24, 28, 30) . The mechanism of VDR binding to VDREs is reflected in the direct repeat nature of the element. Class I members of the nuclear receptor superfamily (e.g., glucocorticoid or progesterone receptor) bind to palindromic response elements as symmetrical homodimers. In contrast, the class II receptors (of which VDR is a member) generally bind to direct repeat elements as asymmetrical heterodimers with RXRs. The direct repeat motif is asymmetrical, and the VDR-RXR heterodimer binds to the VDRE with a defined polarity. VDR and RXR bind to the DR-3 element with RXR occupying the 5Ј half-site and VDR occupying the 3Ј half-site. Because we were interested in the potential regulation of transcription of the surfactant protein genes by VDR, we scanned the available DNA sequences flanking the promoter regions of the human SP-A1 (accession number AY19391), human SP-A2 [accession numbers: AF061969, M68519 (29) ], SP-B [accession number: M24461 (46)], and SP-C [accession number: J03890 (22) ] genes for sequences that correspond to the canonical binding site for the receptors. As shown in Fig. 6 , we found that the DNA sequences surrounding the promoter regions of the three surfactant protein genes contain several perfect VDR-binding halfsites but no "perfect" direct repeats. However, seldom are perfect sites found in well-characterized 1,25(OH) 2 D 3 -regulated genes (28, 30) , suggesting that perfect sites are not required for regulation. Whether VDR binds to these sequences surrounding the SP-A, SP-B, or SP-C promoters requires further study, but at least the possibility exists. We have observed that cAMP seems to make the cells more sensitive to the inhibitory effect of 1,25(OH) 2 D 3 on expression of SP-A and SP-B, but not SP-C. The sequence of the 5Ј-flanking region of the human SP-A promoter indicates of the four potential VDR binding sites, two of them overlap sequence shown to be responsive to cAMP-regulated transcription factors (55), suggesting that interference between the VDR and cAMP-regulated transcription factors may play a part in the reduction of SP-A mRNA levels in the cells when incubated in the presence of Bt 2 cAMP and 1,25(OH) 2 D 3 . In the human SP-B promoter region, the only potential VDR binding site is separated from a potential cAMP protein binding site by 33 base pairs. Although it is not certain whether this region is of a size that is sufficient for interference, the proximity of the sites to each other suggests some type of communication between transcription factors.
The regulation of gene expression by steroid hormone receptors in relation to lung development, differentiation, and morphogenesis is quite complex. In particular, regulation of pulmonary surfactant protein gene expression by steroid hormones and their cognate receptors in fetal lung tissue depends greatly on gestational age, concentration of the steroid hormone, and the context of alveolar type II cells with other lung cell types. We have found that 1,25-(OH) 2 D 3 in general appears to reduce SP-A mRNA levels in fetal lung tissue and reduce SP-A mRNA and protein in isolated type II cells while it increases SP-B mRNA levels in alveolar epithelial type II cells. The hormone appears to have no significant effect on SP-B and SP-C mRNA levels in human fetal lung tissue in organ culture. These results indicate that although 1,25(OH) 2 D 3 has been reported to induce maturation of alveolar type II cells and pulmonary surfactant lipids, it does not induce expression of surfactant proteins in a coordinated manner.
